World Mental Health Survey, Japan, 2002-2006 (ICPSR 39531)

Version Date: Apr 21, 2026 View help for published

Principal Investigator(s): View help for Principal Investigator(s)
Daisuke Nishi, University of Tokyo. Graduate School of Medicine; Norito Kawakami, University of Tokyo. Graduate School of Medicine; Tadashi Takeshima, National Institute of Mental Health, National Center of Neurology and Psychiatry (Japan); Takehiko Kikkawa, National Institute of Mental Health, National Center of Neurology and Psychiatry (Japan); Yutaka Ono, Keio University (Japan). Health Center; Yoshibumi Nakane, Nagasaki International University. Graduate School; Yosikazu Nakamura, Jichi Medical University; Akira Fukao, Yamagata University. Graduate School of Medical Science; Itsuko Horiguchi, Juntendo University. Graduate School of Medicine; Hisateru Tachimori, National Institute of Mental Health, National Center of Neurology and Psychiatry (Japan); Hidenori Uda, Osumi Regional Promotion Bureau, Kagoshima Prefecture; Hideyuki Nakane, Nagasaki University. Graduate School of Biomedical Sciences

Series:

https://doi.org/10.3886/ICPSR39531.v2

Version V2 ()

  • V2 [2026-04-21]
  • V1 [2026-04-21] unpublished
Slide tabs to view more

The World Mental Health (WMH) Survey Initiative was a coordinated series of general population surveys of mental, substance use, and behavioral disorders conducted in countries across all World Health Organization (WHO) regions. The approach taken by WMH was to conduct rigorous general population surveys in nationally representative samples in many countries throughout the world, to generate data from these surveys on the prevalence, severity, course, and treatment of mental disorders. Data were collected using the WHO Composite International Diagnostic Interview (CIDI) which uses both ICD-10 and DSM-III diagnostic criteria. This survey was conducted in Japan and utilized the Japanese version of the CIDI. World Mental Health Survey Japan Survey (First) was conducted from 2002 to 2006.

Nishi, Daisuke, Kawakami, Norito, Takeshima, Tadashi, Kikkawa, Takehiko, Ono, Yutaka, Nakane, Yoshibumi, … Nakane, Hideyuki. World Mental Health Survey, Japan, 2002-2006. Inter-university Consortium for Political and Social Research [distributor], 2026-04-21. https://doi.org/10.3886/ICPSR39531.v2

Export Citation:

  • RIS (generic format for RefWorks, EndNote, etc.)
  • EndNote
Bristol-Myers Squibb Company, United States Department of Health and Human Services. National Institutes of Health. National Institute of Mental Health (R01-MH070884), John D. and Catherine T. MacArthur Foundation, Pfizer Foundation, United States. Public Health Service (R13-MH066849; R01-MH069864; R01-DA016558), United States Department of Health and Human Services. National Institutes of Health. Fogarty International Center (R03-TW006481), Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil, GlaxoSmithKline, Japan. Ministry of Health, Labour and Welfare

This data collection may not be used for any purpose other than statistical reporting and analysis. Use of these data to learn the identity of any person or establishment is prohibited. To protect respondent privacy, the data file in this collection is restricted from general dissemination. To obtain this restricted file, researchers must agree to the terms and conditions of a Restricted Data Use Agreement.

Inter-university Consortium for Political and Social Research
Hide

2002 -- 2006
  1. For additional information on The World Mental Health (WMH) Survey Initiative, please visit The World Mental Health Survey Initiative website.
  2. Supporting documentation to distinguish Part I and II of the survey was not included. Users can utilize crosstabs on the weight variables FINALP1WT and FINALP2WT to determine whether variables in Datasets 1 and 2 were derived from Part I or II of the survey:

    • If a participant without valid values for FINALP2WT responded to a variable, that variable is in Part I of the survey.
    • Variables that only have responses from participants with FINALP2WT valid values are in Part II of the survey.

  3. The Restricted-Use Raw Japan Data were provided without complete variable and value labels, but with a P.I. Questionnaire. This Raw dataset and the corresponding documents are released to provide supplemental information. The Raw dataset is released as Restricted-Use because it contains the original, more granular variables that were used to create the constructed variables in the Public-Use Cleaned Japan Data and the Restricted-Use Cleaned Japan Data.

Hide

The WMH Survey Initiative was designed to fill major gaps in global mental health data. Earlier estimates of the burden of mental and addictive disorders relied largely on literature reviews and isolated studies.WMH surveys provide nationally or regionally representative data to:

  • Estimate the prevalence and distribution of mental, substance use, and behavioral disorders
  • Identify risk and protective factors to inform prevention and intervention strategies
  • Describe patterns of service use, unmet need, and barriers to care
  • Improve estimates of the global burden of disease attributable to mental disorders for public health planning

The survey was administered in two parts. Part I was administered to all respondents. Part II was administered to a probability sub-sample of respondents based on responses to the Part I questions. In addition, a probability subsample of other Part I respondents (i.e., those who did not meet criteria for any core disorder) was also selected to complete Part II, while interviews with the remaining non-cases were ended after the completion of the Part I questions.

Cross-sectional

Japanese speaking citizens aged 20 or older living in group or private residences within three urban cities (Okayama, Nagasaki, Yokohama) and eight rural municipalities (Tamano in Okayama prefecture, Kushikino, Fukiage, Ichiki and Higashi-ichiki in Kagoshima prefecture, Sano in Tochigi prefecture, tendo and Kaminoyama in Yamagata prefecture).

Individual

The overall response rate for this survey was 55.08 percent.

Composite International Diagnostic Interview (CIDI) Version 3.0

Hide

2026-04-21

Hide

The final analysis weight (FINALP1WT) for each respondent was computed as the product of three weight components: the selection weight factor for the respondent, the nonresponse weight adjustment factor for the respondent, and the post-stratification factor for the respondent. The final analysis weight (FINALP2WT) for each respondent administered Part II was computed similarly to FINALP1WT for that subsample of respondents. As a practical matter for analysts, the following decision rules should be applied when selecting the weight to use. When using only variables from Part I, the FINALP1WT weight variable should be used. For analyses with only Part II or a combination of Part I and Part II variables, the Part II weight or FINALP2WT should be used.

Hide

Notes